Percutaneous in Medical Technology

MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation

... Spain, May 20 /PRNewswire/ -- Results show percutaneous mitral repair using the MitraClip(R) system in ... official congress of the European Association of percutaneous Cardiovascular Interventions (EAPCI). MR is ... About the MitraClip (R) Procedure percutaneous mitral repair with Evalve's MitraClip(R) device ...

PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009

... the annual meeting of the European Association of percutaneous Cardiovascular Interventions (EAPCI), May 19-22, ... patient with impaired renal function undergoing a percutaneous Coronary Intervention (PCI). "Following the ... undergoing cardiac catheterization procedures and percutaneous coronary interventions with baseline impairment ...

MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up

... ORLANDO, Fla., March 28 /PRNewswire/ -- percutaneous mitral valve repair using the MitraClip(R) system ... About the MitraClip(R) Procedure percutaneous mitral repair with Evalve's MitraClip(R) device ... has developed a proprietary system which enables percutaneous repair of cardiac valves. The company's initial ...

First Swiss Patients Treated with the Percutaneous MitraClip(R) System

... the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that ... the quality of life of these patients. Now with percutaneous mitral valve repair, I am confident we can expand ... About the MitraClip(R) Procedure percutaneous mitral repair with Evalve's MitraClip(R) device ...

Freezing Kidney Cancer: Hot Treatment Should Be New Gold Standard for Destroying Small Tumors

... studies, examining the safety and efficacy of percutaneous (no incision) cryoablation, show the treatment's ... within a year with a CT scan or MRI. The use of percutaneous cryoablation should not be limited -- as it has ... When comparing the rate of complications between percutaneous cryoablation and surgery, Georgiades said that ...

First U.S. Patients Enrolled in the REALISM Continued Access Study

... the leader in the development of devices for the percutaneous repair of cardiac valves, announced today the ... EVEREST II, the only randomized trial comparing a percutaneous mitral repair device to mitral valve ... About the MitraClip(R) Procedure percutaneous mitral repair with Evalve's MitraClip(R) system ...

Evalve Expands Executive Leadership Team

... the leader in the development of devices for the percutaneous repair of cardiac valves, has expanded its sales ... the company. About the MitraClip Procedure percutaneous mitral repair with Evalve's MitraClip device is ... Inc., and for an animated explanation of the percutaneous Mitral Repair procedure using the MitraClip ...

Evalve Announces Enrollment Completion of the EVEREST Randomized Study

... the leader in the development of devices for the percutaneous repair of cardiac valves, announced today the ... trial. "It is the first randomized trial of any percutaneous mitral repair device compared to mitral valve ... trial sets a high scientific standard for future percutaneous valve therapies. As a result, this trial will ...

PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop

... (rBChE) Therapy Following VX Poisoning by the percutaneous Route: Preliminary Results from Guinea Pig ... poisoning by VX in an animal model which mimics percutaneous exposure. In this model, free agent was measured ... circulating free VX following poisoning by the percutaneous route in animals treated with non-pegylated rBChE ...

First European Patients Treated With the Percutaneous MitraClip(R) System

... the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that ... to treat these patients with a much less invasive percutaneous alternative for mitral repair." "This new ... and trauma." About the MitraClip Procedure percutaneous mitral repair with Evalve's MitraClip device is ...

Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack

... from the Intravascular Cooling Adjunctive to percutaneous Coronary Intervention (ICE-IT) study, a 228 ... Cooling in Myocardial Infarction as Adjunctive to percutaneous Coronary Intervention), is expected to enroll ... as tissue plasminogen activator (tPA) or primary percutaneous coronary intervention (PCI) is the most effective ...

MitraClip Device Preliminary Data Suggests Improved Heart Function and Relief from Heart Failure Symptoms in Functional Mitral Regurgitation Patients

... Patients CHICAGO, April 1, 2008 /PRNewswire/ -- percutaneous mitral repair using the MitraClip(R) device may ... procedure. "It is generally well accepted that percutaneous interventions provide safer and less traumatic ... very pleased with the low complication rate and percutaneous observed in the initial percutaneous mitral valve ...

New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation

... of patients who had a successful result with the percutaneous MitraClip device did not need mitral valve ... "Our work to reduce mitral regurgitation with a percutaneous approach continues to produce compelling ... About the MitraClip Device Procedure Evalve's percutaneous Mitral Repair (PMR) procedure is performed ...

Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned

... non-ST elevation myocardial infarction) for which percutaneous coronary intervention (PCI) is being planned" for ... non-ST elevation myocardial infarction) for which percutaneous coronary intervention (PCI) is planned, Plavix(R) ... 6 ACC/AHA/SCAI 2005 Guideline Update for percutaneous Coronary Intervention: Circulation 113(7): ...

Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study

... antiplatelet therapy (aspirin and clopidogrel) for patients undergoing percutaneous coronary intervention (PCI), commonly known as balloon angioplasty with ... Another important result from the Thrombin Receptor Antagonist percutaneous Coronary Intervention (TRA-PCI) trial was the rate of thrombin-receptor ...

Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System

... officer of Evalve. About the MitraClip(R) Procedure percutaneous mitral repair with Evalve's MitraClip(R) system is performed by physicians ... Menlo Park, California- has developed a proprietary system which enables percutaneous repair of cardiac valves. The company's initial products are intended to ...

Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System

... study of its REG1 Anticoagulation System in patients undergoing elective percutaneous coronary intervention (PCI). REG1 is a two-component system composed of an ... coronary revascularization procedures. These procedures, which include percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), ...

Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System

... therapeutic system in a Phase 2a trial in patients undergoing elective percutaneous coronary intervention. If the results of this study further confirm the ... These procedures, which include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), put patients at a high-risk for ...

Orqis(R) Medical's Cancion(R) System Significantly Increases Cardiac Performance

... of Cardiology (ACC) meeting in Chicago. The MOMENTUM Trial evaluated the percutaneous Cancion System in patients hospitalized with heart failure. Barry ... and more invasive procedures without ever touching the heart. The percutaneous Cancion System has secured the CE mark. The implantable Exeleras(R) System ...

News from the American Heart Association

... treatment strategy." The recommendations clarify that the emphasis on percutaneous coronary intervention (PCI) should not obscure the importance of ... quickly as possible, primarily through the artery opening procedure called percutaneous coronary intervention (PCI). Finally, among the most notable changes ...

Minimally Invasive Treatment Reduces Shoulder Pain From Tendonitis

... treatment or open surgery to remove the calcium. Ultrasound-guided percutaneous (through the skin) therapy represents an effective and inexpensive ... A large-scale study found that minimally invasive, ultrasound-guided percutaneous therapy effectively treats tendonitis caused by calcium deposits in ...

Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions

... REG1 anticoagulation system, is enrolling 26 patients undergoing elective percutaneous coronary intervention (PCI) to assess whether REG1 can replace standard ... These procedures, which include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), put patients at a high-risk for ...

Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting

... being treated with clopidogrel and aspirin at the time of elective percutaneous intervention. Secondary outcomes were the release of markers of myocardial ... including patients who are to be managed medically and those undergoing percutaneous coronary intervention (PCI). It is also indicated in the United States for ...

Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions

... REG1 anticoagulation system, will enroll 26 patients undergoing elective percutaneous coronary intervention (PCI) to assess whether REG1 can replace standard ... These procedures, which include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), put patients at a high-risk for ...

R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023

... in the blood was measured, the level was below the quantification limit as in the case of the single-dose study. As described above, percutaneous absorption of the drug was not high even after continuous application in the morning and at night for 5 days, suggesting hardly any safety problem. ...

Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled

... on the results of the company's VerifyNow P2Y12 Test, reduces major cardiovascular adverse events (e.g., heart attack, stent thrombosis) following percutaneous coronary intervention (PCI). Currently the trial is being conducted at more than 70 sites in the U.S. and Canada, with a total enrollment goal of ...

Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual

... NEW YORK, June 8 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ), a medical technology company testing its proprietary percutaneous hepatic perfusion (PHP(TM)) system for the treatment of cancers of the liver, announced today that it has achieved the seventy-five percent ...

SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine

... answer the question of whether all patients with diabetes and multi-vessel CAD might be better treated with optimal medical therapy (OMT) plus either percutaneous coronary intervention (PCI) or bypass surgery (CABG). Since the BARI-2D study enrolled a very small subset of CAD patients with diabetes, SCAI ...

Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting

... U.S. Medical Centers SAN DIEGO, May 28 /PRNewswire/ -- Celladon Corporation presented today Phase 1 data from the Calcium Up-Regulation by percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID), a First-in-Human Phase 1/2 Clinical Trial, in a scientific symposium at the 12th Annual ...

Lower Extremity Peripheral Vascular Stent and Balloon Catheter Markets to Exceed $180 Million in Europe by 2013

... and the release of new drug-eluting devices for these indications. Combined, these factors will drive the markets for lower extremity PV stents and percutaneous transluminal angioplasty (PTA) balloon catheters to reach combined revenues in excess of $180 million by 2013. The number of endovascular ...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... 36 advanced HCC patients who progressed after various systemic therapies or who were no longer candidates for local therapies, including surgery, percutaneous ablation or transcatheter arterial chemoembolization. Of the 31 patients evaluable in the trial, 16 received everolimus (known as RAD001 in this ...

Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy

... Phase 1/2 Calcium Upregulation by percutaneous Administration (CUPID) Data Highlight Safety Profile and Biological Effects of SERCA2a Enzyme Replacement SAN DIEGO, May 26 /PRNewswire/ -- ...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

... results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial. The results found that percutaneous coronary intervention (PCI) using the TAXUS(R) Express2(R) Paclitaxel-Eluting Coronary Stent System was consistently associated with fewer patient ...

Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent

... data on more than 19,000 patients from the Swedish national registry who were evaluated for restenosis, or the re-narrowing of arteries after percutaneous coronary intervention (PCI). The article reported that patients who received a TAXUS(R) Liberte (R) Paclitaxel-Eluting Stent had numerically lower ...

New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel

... the response to prasugrel. In prasugrel-treated patients with acute coronary syndromes (ACS) who underwent an artery-opening procedure known as percutaneous coronary intervention (PCI), the incidence of the combined endpoint of cardiovascular death, heart attack or stroke was 8.5 percent (N=407) in those ...

Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)

... for the treatment of metastatic melanoma in the liver. Ohio State is the twelfth center to join this multi-center trial testing the Company's percutaneous Hepatic Perfusion (PHP(TM)) System for the isolated, high-dose delivery of the anti-cancer agent melphalan. (Logo: ...

Schering-Plough Announces Results of the Early ACS Trial

... syndrome (unstable angina/non-ST-segment-elevation myocardial infarction), including patients who are to be managed medically and those undergoing percutaneous coronary intervention (PCI). It is also indicated in the United States for the treatment of patients undergoing PCI, including those undergoing ...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease

... and quality of life outcomes, based on one-year data from its landmark SYNTAX trial. The results found that while the overall cost effectiveness of percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) surgery varied according to patient characteristics, PCI was more cost ...

Dr. James F. Pingpank to Present at Leading Regional Therapies Conference

... NEW YORK, Feb. 19 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ), a medical technology company testing its proprietary percutaneous Hepatic Perfusion ("PHP(TM)") System for the treatment of cancers of the liver, announced today that Dr. James F. Pingpank will present at The Fourth ...

New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial

... welcomed the publication of results from its landmark SYNTAX(TM) trial in this week's issue of the New England Journal of Medicine. In the study, percutaneous coronary intervention (PCI) using the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System was compared to contemporary coronary artery ...